| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6241239 | Respiratory Medicine | 2016 | 35 Pages |
Abstract
Once-daily umeclidinium/vilanterol significantly improved lung function in patients with COPD, with quantitatively greater improvements in patients identified as responders to umeclidinium and vilanterol monotherapy than non-responders.
Related Topics
Health Sciences
Medicine and Dentistry
Pulmonary and Respiratory Medicine
Authors
James F. Donohue, Dave Singh, Clara Munzu, Sally Kilbride, Alison Church,